Gijs van Haaften
Utrecht University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Gijs van Haaften.
Nature Genetics | 2009
Gijs van Haaften; Gillian L. Dalgliesh; Helen Davies; Lina Chen; Graham R. Bignell; Christopher Greenman; Sarah Edkins; Claire Hardy; Sarah O'Meara; Jon Teague; Adam Butler; Jonathan Hinton; Calli Latimer; Jenny Andrews; Syd Barthorpe; Dave Beare; Gemma Buck; Peter J. Campbell; Jennifer Cole; Simon A. Forbes; Mingming Jia; David Jones; Chai Yin Kok; Catherine Leroy; Meng-Lay Lin; David J. McBride; Mark Maddison; Simon Maquire; Kirsten McLay; Andrew Menzies
Somatically acquired epigenetic changes are present in many cancers. Epigenetic regulation is maintained via post-translational modifications of core histones. Here, we describe inactivating somatic mutations in the histone lysine demethylase gene UTX, pointing to histone H3 lysine methylation deregulation in multiple tumor types. UTX reintroduction into cancer cells with inactivating UTX mutations resulted in slowing of proliferation and marked transcriptional changes. These data identify UTX as a new human cancer gene.
Nature Genetics | 2012
Magdalena Harakalova; Jeske van Harssel; Paulien A. Terhal; Stef van Lieshout; Karen Duran; Ivo Renkens; David J. Amor; Louise C. Wilson; Edwin P. Kirk; Claire Turner; Debbie Shears; Sixto García-Miñaúr; Melissa Lees; Alison Ross; Hanka Venselaar; Gert Vriend; Hiroki Takanari; Martin B. Rook; Marcel A.G. van der Heyden; Folkert W. Asselbergs; Hans M Breur; Marielle Swinkels; Ingrid Scurr; Sarah F. Smithson; Nine V.A.M. Knoers; Jasper J. van der Smagt; Isaac J. Nijman; Wigard P. Kloosterman; Mieke M. van Haelst; Gijs van Haaften
Cantú syndrome is characterized by congenital hypertrichosis, distinctive facial features, osteochondrodysplasia and cardiac defects. By using family-based exome sequencing, we identified a de novo mutation in ABCC9. Subsequently, we discovered novel dominant missense mutations in ABCC9 in 14 of the 16 individuals with Cantú syndrome examined. The ABCC9 protein is part of an ATP-dependent potassium (KATP) channel that couples the metabolic state of a cell with its electrical activity. All mutations altered amino acids in or close to the transmembrane domains of ABCC9. Using electrophysiological measurements, we show that mutations in ABCC9 reduce the ATP-mediated potassium channel inhibition, resulting in channel opening. Moreover, similarities between the phenotype of individuals with Cantú syndrome and side effects from the KATP channel agonist minoxidil indicate that the mutations in ABCC9 result in channel opening. Given the availability of ABCC9 antagonists, our findings may have direct implications for the treatment of individuals with Cantú syndrome.
Gastroenterology | 2014
Caroline L. Wiegerinck; Andreas R. Janecke; Kerstin Schneeberger; Georg F. Vogel; Désirée Y. van Haaften–Visser; Johanna C. Escher; Rüdiger Adam; Cornelia E. Thöni; Kristian Pfaller; Alexander J. Jordan; Cleo Aron Weis; Isaac J. Nijman; Glen R. Monroe; Peter M. van Hasselt; Ernest Cutz; Judith Klumperman; Hans Clevers; Edward E. S. Nieuwenhuis; Roderick H. J. Houwen; Gijs van Haaften; Michael W. Hess; Lukas A. Huber; Janneke M. Stapelbroek; Thomas Müller; Sabine Middendorp
Microvillus inclusion disease (MVID) is a disorder of intestinal epithelial differentiation characterized by life-threatening intractable diarrhea. MVID can be diagnosed based on loss of microvilli, microvillus inclusions, and accumulation of subapical vesicles. Most patients with MVID have mutations in myosin Vb that cause defects in recycling of apical vesicles. Whole-exome sequencing of DNA from patients with variant MVID showed homozygous truncating mutations in syntaxin 3 (STX3). STX3 is an apical receptor involved in membrane fusion of apical vesicles in enterocytes. Patient-derived organoid cultures and overexpression of truncated STX3 in Caco-2 cells recapitulated most characteristics of variant MVID. We conclude that loss of STX3 function causes variant MVID.
Genetics in Medicine | 2016
Glen R. Monroe; Gerardus W.J. Frederix; Sanne M. C. Savelberg; Tamar I. de Vries; Karen Duran; Jasper J. van der Smagt; Paulien A. Terhal; Peter M. van Hasselt; Hester Y. Kroes; Nanda M. Verhoeven-Duif; Isaac J. Nijman; Ellen C. Carbo; Koen L.I. van Gassen; Nine V.A.M. Knoers; Anke M. Hövels; Mieke M. van Haelst; Gepke Visser; Gijs van Haaften
Purpose:This study investigated whole-exome sequencing (WES) yield in a subset of intellectually disabled patients referred to our clinical diagnostic center and calculated the total costs of these patients’ diagnostic trajectory in order to evaluate early WES implementation.Methods:We compared 17 patients’ trio-WES yield with the retrospective costs of diagnostic procedures by comprehensively examining patient records and collecting resource use information for each patient, beginning with patient admittance and concluding with WES initiation. We calculated cost savings using scenario analyses to evaluate the costs replaced by WES when used as a first diagnostic tool.Results:WES resulted in diagnostically useful outcomes in 29.4% of patients. The entire traditional diagnostic trajectory average cost was
Journal of Medical Genetics | 2012
Magdalena Harakalova; Marie-José H. van den Boogaard; Richard J. Sinke; Stef van Lieshout; Marc van Tuil; Karen Duran; Ivo Renkens; Paulien A. Terhal; Carolien G.F. de Kovel; Ies Nijman; Mieke M. van Haelst; N.V.A.M. Knoers; Gijs van Haaften; Wigard P. Kloosterman; Raoul C. M. Hennekam; Edwin Cuppen; Hans Kristian Ploos van Amstel
16,409 per patient, substantially higher than the
Human Mutation | 2014
Paige E. Cooper; Heiko Reutter; Joachim Woelfle; Hartmut Engels; Dorothy K. Grange; Gijs van Haaften; Bregje W.M. van Bon; Alexander Hoischen; Colin G. Nichols
3,972 trio-WES cost. WES resulted in average cost savings of
The EMBO Journal | 2007
Ester W Frische; Wendy Pellis-van Berkel; Gijs van Haaften; Edwin Cuppen; Ronald H.A. Plasterk; Marcel Tijsterman; Johannes L. Bos; Fried J. T. Zwartkruis
3,547 for genetic and metabolic investigations in diagnosed patients and
American Journal of Human Genetics | 2015
Maarten P. G. Massink; Marijn Créton; Francesca Spanevello; Willem Fennis; Marco S. Cune; Sanne M. C. Savelberg; Isaac J. Nijman; Madelon M. Maurice; Marie-José H. van den Boogaard; Gijs van Haaften
1,727 for genetic investigations in undiagnosed patients.Conclusion:The increased causal variant detection yield by WES and the relatively high costs of the entire traditional diagnostic trajectory suggest that early implementation of WES is a relevant and cost-efficient option in patient diagnostics. This information is crucial for centers considering implementation of WES and serves as input for future value-based research into diagnostics.Genet Med 18 9, 949–956.
American Journal of Physiology-endocrinology and Metabolism | 2012
Joram D. Mul; Denovan P. Begg; Suzanne I. M. Alsters; Gijs van Haaften; Karen Duran; David A. D'Alessio; Carel W. le Roux; Stephen C. Woods; Darleen A. Sandoval; Alexandra I. F. Blakemore; Edwin Cuppen; Mieke M. van Haelst; Randy J. Seeley
Background We present a large Dutch family with seven males affected by a novel syndrome of X-linked intellectual disability, hypogonadism, gynaecomastia, truncal obesity, short stature and recognisable craniofacial manifestations resembling but not identical to Wilson-Turner syndrome. Seven female relatives show a much milder expression of the phenotype. Methods and results We performed X chromosome exome (X-exome) sequencing in five individuals from this family and identified a novel intronic variant in the histone deacetylase 8 gene (HDAC8), c.164+5G>A, which disturbs the normal splicing of exon 2 resulting in exon skipping, and introduces a premature stop at the beginning of the histone deacetylase catalytic domain. The identified variant completely segregates in this family and was absent in 96 Dutch controls and available databases. Affected female carriers showed a notably skewed X-inactivation pattern in lymphocytes in which the mutated X-chromosome was completely inactivated. Conclusions HDAC8 is a member of the protein family of histone deacetylases that play a major role in epigenetic gene silencing during development. HDAC8 specifically controls the patterning of the skull with the mouse HDAC8 knock-out showing craniofacial deformities of the skull. The present family provides the first evidence for involvement of HDAC8 in a syndromic form of intellectual disability.
The New England Journal of Medicine | 2014
Peter M. van Hasselt; Sacha Ferdinandusse; Glen R. Monroe; Marjolein Turkenburg; Maartje J. Geerlings; Karen Duran; Magdalena Harakalova; Bert van der Zwaag; Ardeshir A. Monavari; Ilyas Okur; Mark J. Sharrard; Maureen Cleary; Valerie Walker; M. Estela Rubio; Maaike C. de Vries; Gepke Visser; Jasper J. van der Smagt; Nanda M. Verhoeven; Gijs van Haaften
ATP‐sensitive potassium (KATP) channels, composed of inward‐rectifying potassium channel subunits (Kir6.1 and Kir6.2, encoded by KCNJ8 and KCNJ11, respectively) and regulatory sulfonylurea receptor (SUR1 and SUR2, encoded by ABCC8 and ABCC9, respectively), couple metabolism to excitability in multiple tissues. Mutations in ABCC9 cause Cantú syndrome (CS), a distinct multiorgan disease, potentially via enhanced KATP channel activity. We screened KCNJ8 in an ABCC9 mutation‐negative patient who also exhibited clinical hallmarks of CS (hypertrichosis, macrosomia, macrocephaly, coarse facial appearance, cardiomegaly, and skeletal abnormalities). We identified a de novo missense mutation encoding Kir6.1[p.Cys176Ser] in the patient. Kir6.1[p.Cys176Ser] channels exhibited markedly higher activity than wild‐type channels, as a result of reduced ATP sensitivity, whether coexpressed with SUR1 or SUR2A subunits. Our results identify a novel causal gene in CS, but also demonstrate that the cardinal features of the disease result from gain of KATP channel function, not from a Kir6‐independent SUR2 function.